MicroRNA-Restricted Transgene Expression in the Retina
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Gene transfer using adeno-associated viral (AAV) vectors has been successfully applied in the retina for the treatment of inherited retinal dystrophies. Recently, microRNAs have been exploited to fine-tune transgene expression improving therapeutic outcomes. Here we evaluated the ability of retinal-expressed microRNAs to restrict AAV-mediated transgene expression to specific retinal cell types that represent the main targets of common inherited blinding conditions. METHODOLOGY/PRINCIPAL FINDINGS: To this end, we generated AAV2/5 vectors expressing EGFP and containing four tandem copies of miR-124 or miR-204 complementary sequences in the 3'UTR of the transgene expression cassette. These vectors were administered subretinally to adult C57BL/6 mice and Large White pigs. Our results demonstrate that miR-124 and miR-204 target sequences can efficiently restrict AAV2/5-mediated transgene expression to retinal pigment epithelium and photoreceptors, respectively, in mice and pigs. Interestingly, transgene restriction was observed at low vector doses relevant to therapy. CONCLUSIONS: We conclude that microRNA-mediated regulation of transgene expression can be applied in the retina to either restrict to a specific cell type the robust expression obtained using ubiquitous promoters or to provide an additional layer of gene expression regulation when using cell-specific promoters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 miR-124 and miR-204 expression in retina supports the use of AAV vectors harboring corresponding miRTs. (a) Expression profile of miR-204 and miR-124 in retina sections of adult, albino (CD1) mouse as revealed by ISH using LNA-modified probes. miR-124, a neuronal-specific miRNA, is expressed in all layers of the neural retina but is not detected in the RPE. miR-204 is expressed in the GCL and the INL of the neural retina and stains strongly the RPE. RNA ISH for the detection of mature miRNAs was performed using miRCURY LNA™ microRNA Detection Probes (Exiqon, Vedbaek, Denmark) as previously described [26]. (b) Schematic representation of the AAV vectors harboring the miRT sites. Four tandem copies (4xmiRT) of a sequence perfectly complementary to the sequence of the mature miR-124 or miR-204 (see alignments) were cloned downstream of the WPRE element in the pAAV2.1-CMV-EGFP plasmid. Abbreviations are as follows: CMV, Human Cytomegalovirus promoter; EGFP, Enhanced Green Fluorescence Protein; GCL, Ganglion Cell Layer; INL, Inner Nuclear Layer; IPL, Inner Plexiform Layer; ITR, Inverted Terminal Repeat; miRT, miRNA target site; ONL, Photoreceptor Outer Nuclear Layer; OS, Photoreceptor Outer Segments; RPE, Retinal Pigment Epithelium; WPRE, Woodchuck hepatitis virus Post-transcriptional Regulatory Element.](https://figures.cochat.ai/paper-figures/4998b759e3514e9d9a043545e2d40cae/microrna-restricted-transgene-expression-in-the-retina-figure-1.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, adding 4× the complementary sequence of miR-124 removed the expression in photoreceptors [145].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [145]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“4× miRNA placed in an rAAV-CMV expression cassette generally is sufficient for miRNA expression without inducing side-effects [145].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [145]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Adding 4× the complementary sequence of miRNA204 to a rAAV2/5.CMV.eGFP.WPRE.4xmiRNA204Tsignificantly reduced eGFP expression in RPE cells after subretinal injection in mice and pigs.”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [145]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.040 · Cited by 3,626 · cited 1×
“MiRNAs predominantly act to decrease target mRNA levels in animal cells [1] and at least one third of them are expressed in a cell type- or developmental-specific manner [2].”
BackgroundIdentification of tissue-specific microRNAs from mouse
Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W., & Tuschl, T. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00809-6 · Cited by 3,355 · cited 1×
“To restrict AAV2/5-CMV-mediated transgene expression to the RPE, we exploited miR-124, a miRNA abundantly expressed in differentiated neurons [30].”
Gene silencing by microRNAs: contributions of translational repression and mRNA decay
Huntzinger, E., & Izaurralde, E. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2936 · Cited by 2,339 · cited 2×
“MiRNAs predominantly act to decrease target mRNA levels in animal cells [1] and at least one third of them are expressed in a cell type- or developmental-specific manner [2].”
BackgroundSafety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145 · cited 3×
“The safety and efficacy of AAV-based gene therapy has been verified in various animal models [13] and in humans [14,15,16,17,18,19,20,21].”
BackgroundSelf-citationEffect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924 · cited 2×
“The safety and efficacy of AAV-based gene therapy has been verified in various animal models [13] and in humans [14,15,16,17,18,19,20,21].”
BackgroundMicroRNA Expression in Zebrafish Embryonic Development
Wienholds, E., Kloosterman, W. P., Miska, E., Alvarez-Saavedra, E., Berezikov, E., de Bruijn, E., Horvitz, H. R., Kauppinen, S., & Plasterk, R. H. A. (2005) · Science · doi:10.1126/science.1114519 · Cited by 1,551 · cited 1×
“Given the highly conserved cellular distribution of these two miRNAs across species [26,34,35], we assumed that miR-124 and miR-204 are likely to be expressed in the same porcine retinal layers.”
BackgroundHauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.107 · Cited by 954 · cited 2×
“The safety and efficacy of AAV-based gene therapy has been verified in various animal models [13] and in humans [14,15,16,17,18,19,20,21].”
BackgroundMaguire, A. M., High, K. A., Auricchio, A., Wright, J. F., Pierce, E. A., Testa, F., Mingozzi, F., Bennicelli, J. L., Ying, G.-S., Rossi, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61836-5 · Cited by 865 · cited 3×
“The safety and efficacy of AAV-based gene therapy has been verified in various animal models [13] and in humans [14,15,16,17,18,19,20,21].”
BackgroundSelf-citationCideciyan, A. V., Aleman, T. S., Boye, S. L., Schwartz, S. B., Kaushal, S., Roman, A. J., Pang, J.-J., Sumaroka, A., Windsor, E. A. M., Wilson, J. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807027105 · Cited by 673
Genomic Analysis of Mouse Retinal Development
Blackshaw, S., Harpavat, S., Trimarchi, J., Cai, L., Huang, H., Kuo, W. P., Weber, G., Lee, K., Fraioli, R. E., Cho, S.-H., et al. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020247 · Cited by 585
Research works printed but not linked: 2
- McGraw-Hill Kaplan J, Rozet J-M, Perrault I, Munnich A Leber Congetital Amaurosis. The Online Metabolic & Molecular Bases of Inherited Diseases
- Brunetti-Pierri N Auricchio A 2010 Gene Therapy of Human Inherited Diseases. McGraw-Hill The Online Metabolic & Molecular Bases of Inherited Disease
Cited by
AAV-Mediated Gene Therapy for Research and Therapeutic Purposes
Samulski, R. J., & Muzyczka, N. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085355 · Cited by 551
Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality
Hudry, E., & Vandenberghe, L. H. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.017 · Cited by 369
AAV vectors: The Rubik’s cube of human gene therapy
Pupo, A., Fernández, A., Low, S. H., François, A., Suárez-Amarán, L., & Samulski, R. J. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.09.015 · Cited by 360
Vector platforms for gene therapy of inherited retinopathies
Trapani, I., Puppo, A., & Auricchio, A. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.08.001 · Cited by 183
Self-citationViral Strategies for Targeting the Central and Peripheral Nervous Systems
Bedbrook, C. N., Deverman, B. E., & Gradinaru, V. (2018) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-080317-062048 · Cited by 168
Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors
Kay, C. N., Ryals, R. C., Aslanidi, G. V., Min, S. H., Ruan, Q., Sun, J., Dyka, F. M., Kasuga, D., Ayala, A. E., Van Vliet, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062097 · Cited by 168
“Similar to methods previously described, [32] we further restricted transgene expression to PRs by incorporating multiple target sequences for miR181, an miRNA endogenously expressed in cells of the inner and middle retina.”
MethodControlling AAV Tropism in the Nervous System with Natural and Engineered Capsids
Castle, M. J., Turunen, H. T., Vandenberghe, L. H., & Wolfe, J. H. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-3271-9_10 · Cited by 151
“However, binding sites for the RPE-specifi c miR-204 can block AAV5-mediated gene expression in RPE cells, resulting in PR-specifi c expression [ 130 ].”
BackgroundTriple Vectors Expand AAV Transfer Capacity in the Retina
Maddalena, A., Tornabene, P., Tiberi, P., Minopoli, R., Manfredi, A., Mutarelli, M., Rossi, S., Simonelli, F., Naggert, J. K., Cacchiarelli, D., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2017.11.019 · Cited by 128
Self-citationClinical applications of retinal gene therapy
Lipinski, D. M., Thake, M., & MacLaren, R. E. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.09.001 · Cited by 132
Efficient gene delivery to the cone-enriched pig retina by dual AAV vectors
Colella, P., Trapani, I., Cesi, G., Sommella, A., Manfredi, A., Puppo, A., Iodice, C., Rossi, S., Simonelli, F., Giunti, M., et al. (2014) · Gene Therapy · doi:10.1038/gt.2014.8 · Cited by 103
Self-citationBuck, T., & Wijnholds, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124197 · Cited by 92
MicroRNA-regulated viral vectors for gene therapy
Geisler, A., & Fechner, H. (2016) · World Journal of Experimental Medicine · doi:10.5493/wjem.v6.i2.37 · Cited by 93
Trapani, I., Toriello, E., de Simone, S., Colella, P., Iodice, C., Polishchuk, E. V., Sommella, A., Colecchi, L., Rossi, S., Simonelli, F., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv386 · Cited by 94
Self-citationImproving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors
Herrera-Carrillo, E., Liu, Y. P., & Berkhout, B. (2017) · Human Gene Therapy Methods · doi:10.1089/hgtb.2017.036 · Cited by 86
Retinal miRNA Functions in Health and Disease
Žužić, M., Arias, J. E. R., Wohl, S. G., & Busskamp, V. (2019) · Genes · doi:10.3390/genes10050377 · Cited by 84
Chu-Tan, J. A., Rutar, M., Saxena, K., Aggio-Bruce, R., Essex, R. W., Valter, K., Jiao, H., Fernando, N., Wooff, Y., Madigan, M. C., et al. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-24623 · Cited by 65
The microRNA expression profile of mouse Müller glia in vivo and in vitro
Wohl, S. G., & Reh, T. A. (2016) · Scientific Reports · doi:10.1038/srep35423 · Cited by 69
Gene therapy and neurodevelopmental disorders
Gray, S. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.024 · Cited by 64
The physiological impact of microRNA gene regulation in the retina
Sundermeier, T. R., & Palczewski, K. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0976-7 · Cited by 59
Greig, J. A., Peng, H., Ohlstein, J., Medina-Jaszek, C. A., Ahonkhai, O., Mentzinger, A., Grant, R. L., Roy, S., Chen, S.-J., Bell, P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112268 · Cited by 55
Meng, W., Butterworth, J. A., Bradley, D., Hughes, A. E., Soler, V. J., Calvas, P., & Malecaze, F. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10409 · Cited by 54
Taschenberger, G., Tereshchenko, J., & Kügler, S. (2017) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2017.03.009 · Cited by 53
Wang, J.-H., Zhan, W., Gallagher, T. L., & Gao, G. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.10.017 · Cited by 53
Zhang, Z., Qin, X., & Zhang, J. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00444.2018 · Cited by 49
MicroRNAs in the Neural Retina
Andreeva, K., & Cooper, N. G. F. (2014) · International Journal of Genomics · doi:10.1155/2014/165897 · Cited by 49
TRPM3_miR-204: a complex locus for eye development and disease
Shiels, A. (2020) · Human Genomics · doi:10.1186/s40246-020-00258-4 · Cited by 47
Chen, N., Wang, J., Hu, Y., Cui, B., Li, W., Xu, G., Liu, L., & Liu, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095665 · Cited by 47
Combined Rod and Cone Transduction by Adeno-Associated Virus 2/8
Manfredi, A., Marrocco, E., Puppo, A., Cesi, G., Sommella, A., Della Corte, M., Rossi, S., Giunti, M., Craft, C. M., Bacci, M. L., et al. (2013) · Human Gene Therapy · doi:10.1089/hum.2013.154 · Cited by 43
Self-citationMicroRNAs Are Involved in End-Organ Damage During Hypertension
Heggermont, W., & Heymans, S. R. B. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.187104 · Cited by 44
CaMKIIα-Positive Interneurons Identified via a microRNA-Based Viral Gene Targeting Strategy
Keaveney, M. K., Rahsepar, B., Tseng, H.-A., Fernandez, F. R., Mount, R. A., Ta, T. L., White, J. A., Berg, J., & Han, X. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2570-19.2020 · Cited by 45
Geisler, A., Schön, C., Größl, T., Pinkert, S., Stein, E. A., Kurreck, J., Vetter, R., & Fechner, H. (2013) · Molecular Therapy · doi:10.1038/mt.2012.276 · Cited by 36
Genetic approaches to access cell types in mammalian nervous systems
He, M., & Huang, Z. J. (2018) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2018.02.003 · Cited by 34
Rationally Designed MicroRNA-Based Genetic Classifiers Target Specific Neurons in the Brain
Sayeg, M. K., Weinberg, B. H., Cha, S. S., Goodloe, M., Wong, W. W., & Han, X. (2015) · ACS Synthetic Biology · doi:10.1021/acssynbio.5b00040 · Cited by 35
Non-coding RNAs in the development of sensory organs and related diseases
Conte, I., Banfi, S., & Bovolenta, P. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1335-z · Cited by 33
Self-citationMicroRNA-Regulated Gene Delivery Systems for Research and Therapeutic Purposes
Dhungel, B. P., Ramlogan‐Steel, C. A., & Steel, J. C. (2018) · Molecules · doi:10.3390/molecules23071500 · Cited by 35
Baker, L. A., Lee, K. C. L., Jiménez, C. P., Alibhai, H. I., Chang, Y., Leckie, P. J., Mookerjee, R. P., Davies, N. A., Andreola, F., & Jalan, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128076 · Cited by 31
Development of gene therapy for treatment of age‐related macular degeneration
Askou, A. L. (2014) · Acta Ophthalmologica · doi:10.1111/aos.12452 · Cited by 35
Kang, S., Larbi, D., Andrade, M., Reardon, S., Reh, T. A., & Wohl, S. G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.620459 · Cited by 30
Zhang, C., Miyagishima, K. J., Dong, L., Rising, A., Nimmagadda, M., Liang, G., Sharma, R., Dejene, R., Wang, Y., Abu-Asab, M., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz171 · Cited by 26
“Although miR-204 has been reported to be expressed in the ganglion and the inner nuclear layers (INLs) of the retina (18), the retinal thickness did not appear to be adversely affected in miR-204−/− mice (Supplementary Material, Fig.”
BackgroundThe role of miRNA in retinal ganglion cell health and disease
Mead, B., & Tomarev, S. I. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.320974 · Cited by 24
Antiangiogenic Eye Gene Therapy
Corydon, T. J. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.064 · Cited by 21
Kay, C. N., Ryals, R. C., Aslanidi, G., Min, S.-H., Ruan, Q., Sun, J., Dyka, F. M., Kasuga, D. T., Ayala, A. E., Vliet, K. V., et al. (2013) · PLoS ONE · doi:10.1371/annotation/99ee1789-a658-4fb0-8593-40a40e9f344a · Cited by 18
Ma, Y., Dong, C., Chen, X., Zhu, R., & Wang, J. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s299143 · Cited by 17
Oscillatory Behaviors of microRNA Networks: Emerging Roles in Retinal Development
Fishman, E. S., Han, J. S., & La Torre, A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.831750 · Cited by 16
Reid, C. A., Boye, S. L., Hauswirth, W. W., & Lipinski, D. M. (2017) · Gene Therapy · doi:10.1038/gt.2017.50 · Cited by 16
Curell, R. V., & Barron, N. (2018) · Biotechnology Journal · doi:10.1002/biot.201700220 · Cited by 17
Carrella, S., Banfi, S., & Karali, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.629158 · Cited by 14
Self-citationDeveloping New Vectors for Retinal Gene Therapy
Zin, E. A., Öztürk, B. E., Dalkara, D., & Byrne, L. C. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041291 · Cited by 14
miR Cluster 143/145 Directly Targets Nrl and Regulates Rod Photoreceptor Development
Sreekumaran, S., Rasheed, V. A., Lalitha, S., Antony, J., Saikia, M., Sivakumar, K. C., & Das, A. V. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0237-0 · Cited by 9
Transdermal spinal catheter placement in piglets: Description and validation of the technique
Lambertini, C., Ventrella, D., Barone, F., Sorrentino, N. C., Dondi, F., Fraldi, A., Giunti, M., Surace, E. M., Bacci, M. L., & Romagnoli, N. (2015) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2015.07.021 · Cited by 10
Self-citationAbe, M., Kawaguchi, H., Miura, N., Akioka, K., Ushikai, M., Oi, S., Yukawa, A., Yoshikawa, T., Izumi, H., & Horiuchi, M. (2018) · In Vivo · doi:10.21873/invivo.11279 · Cited by 9
Bicistronic Gene Transfer Tools for Delivery of miRNAs and Protein Coding Sequences
Stoller, M. L., Chang, H. C., & Fekete, D. M. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140918239 · Cited by 8
Selection of UTRs in mRNA-Based Gene Therapy and Vaccines
Volkhin, I. A., Paremskaia, A. I., Dashian, M. A., Smeshnova, D. S., Pavlov, R. E., Mityaeva, O. N., Volchkov, P. Y., & Deviatkin, A. A. (2025) · Biochemistry (Moscow) · doi:10.1134/s0006297924604659 · Cited by 7
Cong, W., Shi, Y., Qi, Y., Wu, J., Gong, L., & He, M. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108629 · Cited by 8
Chang, C.-W., Wang, L.-S., Pham, N. N., Shen, C., Hsu, M., Nguyen, N. T. K., Yen, C.-Y., Lin, M., Hwu, J. R., Chang, Y., et al. (2021) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2021.104175 · Cited by 4
Toward improved AAV gene therapies for retinal disorders: challenges and advances
Siontas, O., Brown, M., & Ahn, S. (2025) · Regenerative Medicine · doi:10.1080/17460751.2025.2544497 · Cited by 3
Moyle, R., Sternes, P. R., & Birch, R. G. (2014) · Plant Molecular Biology Reporter · doi:10.1007/s11105-014-0765-6 · Cited by 3
Askou, A. L., & Corydon, T. J. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2389-2_3
Ishii, D., Nishikawa, Y., Soeda, M., Tonomura, Y., Numakura, Y., Kitsunai, Y., Osawa, Y., Asakura, K., & Yamashita, Y. (2025) · Journal of Applied Toxicology · doi:10.1002/jat.4775
Disabling Müller Glia Preserves Retinal Function After Retinal InjuryPreprint
Larbi, D., Chen, S., Gibbons, L. D., Indictor, A., Kang, S., Rief, A. M., & Wohl, S. G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.14.718211
Metadata
- Authors
- Karali, M., Manfredi, A., Puppo, A., Marrocco, E., Gargiulo, A., Allocca, M., Corte, M. D., Rossi, S., Giunti, M., Bacci, M. L., Simonelli, F., Surace, E. M., Banfi, S., & Auricchio, A.
- Affiliations
- Telethon Institute Of Genetics And Medicine (IT)
- University of Campania "Luigi Vanvitelli" (IT)
- University of Bologna (IT)
- Federico II University Hospital (IT)
- Corresponding author
- Banfi, Sandro
- Auricchio, Alberto
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-07-26
- Volume
- 6
- Issue
- 7
- Pages
- e22166
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3144214
- OpenAlex
- W1976338469
- Cited by
- 60
- References
- 50
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 5 · 2020: 4 · 2019: 4 · 2018: 6 · 2017: 4 · 2016: 3 · 2015: 7 · 2014: 8 · 2013: 6 · 2012: 5
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion, cc-by)
- Funders
- University of Southern California
- University College London
- European Commission (231068, 223445, 242013)
- Fondazione Telethon
- Ministero della Salute
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- microRNA, adeno-associated virus vectors, AAV2/5, transgene expression regulation, miR-124, miR-204, 3' untranslated region, retinal pigment epithelium, photoreceptors, inherited retinal disease, pigs
- MeSH terms
- Dependovirus, Animals, Base Sequence, Gene Expression Regulation, Genetic Vectors, Humans, Mice, Inbred C57BL, Molecular Sequence Data, Organ Specificity, Retina, Transduction, Genetic, Transgenes, Photoreceptor Cells, Vertebrate, Sus scrofa, MicroRNAs, Green Fluorescent Proteins, Mice, Retinal Pigment Epithelium
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.